CYOU [Changyou.com] UPLOAD: (Original Filing)
[]
[ChinaNet Online Announces Preliminary Third Quarter Financial Results and Full Year 2011 Revenue Guidance; Company Provides Business Update Q3 Revenues and Adjusted Net income expected to be at least $6.2 million and $1.0 million, respectively BEIJING, Nov. 10, 2011 -- ChinaNet Online Holdings, Inc. ("ChinaNet") (Nasdaq: CNET), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline]
[China Zenix Auto International Announces 45.5% Increase in Net Profit in Third Quarter of 2011 - Gross margin of 26.0%, Earnings per ADS of $0.27 - ZHANGZHOU, China, November 10, 2011 China Zenix Auto International Limited Financial Highlights Third Quarter 2011: Revenue increased 14.9% to RMB894.6 million (US$140.3 million) from RMB778.9 million in the third quarter of 2010;]
[ChinaNet Online Announces Preliminary Third Quarter Financial Results and Full Year 2011 Revenue Guidance; Company Provides Business Update Q3 Revenues and Adjusted Net income expected to be at least $6.2 million and $1.0 million, respectively BEIJING, Nov. 10, 2011 -- ChinaNet Online Holdings, Inc. ("ChinaNet") (Nasdaq: CNET), a leading B2B (business to business) Internet technology company focusing on providing online-to-offline]
[China Zenix Auto International Announces 45.5% Increase in Net Profit in Third Quarter of 2011 - Gross margin of 26.0%, Earnings per ADS of $0.27 - ZHANGZHOU, China, November 10, 2011 China Zenix Auto International Limited Financial Highlights Third Quarter 2011: Revenue increased 14.9% to RMB894.6 million (US$140.3 million) from RMB778.9 million in the third quarter of 2010;]
[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page No. 3 PART I. FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets as of September 30, 2011 (unaudited) and December 31, 2010 F-1 Condensed Consolidated Statements of Income and Other Comprehensive Income for the Three and Nine Months Ended September 30, 2011 and 2010 (unaudited) F-2 Condensed Consolidated] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer November 14, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer November 14, 2011]
[SKYSTAR BIO-PHARMACEUTICAL COMPANY FORM 10-Q INDEX Page No. 3 PART I. FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets as of September 30, 2011 (unaudited) and December 31, 2010 F-1 Condensed Consolidated Statements of Income and Other Comprehensive Income for the Three and Nine Months Ended September 30, 2011 and 2010 (unaudited) F-2 Condensed Consolidated] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of SKYSTAR BIO-PHARMACEUTICAL COMPANY; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer November 14, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer November 14, 2011]
[Home Inns Reports Third Quarter 2011 Financial Results Revenue Increased 12% Year over Year to RMB 988 million Shanghai, November 10, 2011 Third Quarter 2011 Financial Highlights Total revenue for the third quarter of 2011 was RMB 988.0 million (US$154.9 million) representing a 12.3% year-over-year increase, exceeding the guidance range of RMB 955 million to RMB 975 million,]